SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017456
Filing Date
2023-05-04
Accepted
2023-05-04 07:09:16
Documents
81
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q omga-20230331.htm   iXBRL 10-Q 2757160
2 EX-10.1 omga-ex10_1.htm EX-10 488050
3 EX-31.1 omga-ex31_1.htm EX-31 20706
4 EX-31.2 omga-ex31_2.htm EX-31 20420
5 EX-32.1 omga-ex32_1.htm EX-32 11879
6 EX-32.2 omga-ex32_2.htm EX-32 11578
  Complete submission text file 0000950170-23-017456.txt   10177040

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT omga-20230331_pre.xml EX-101.PRE 387086
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT omga-20230331.xsd EX-101.SCH 69622
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT omga-20230331_cal.xml EX-101.CAL 49591
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT omga-20230331_lab.xml EX-101.LAB 531209
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT omga-20230331_def.xml EX-101.DEF 227474
75 EXTRACTED XBRL INSTANCE DOCUMENT omga-20230331_htm.xml XML 1617958
Mailing Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 (617) 949-4360
Omega Therapeutics, Inc. (Filer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40657 | Film No.: 23886421
SIC: 2836 Biological Products, (No Diagnostic Substances)